Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-24 @ 7:42 PM
NCT ID:
NCT05881603
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years old
* Diagnosis of cardiogenic Acute Pulmonary Edema defined by the association of clinical acute respiratory distress (current breath rate \> 25/min, indrawing, flapping of the wings of the nose, thoraco-abdominal rocking, signs of hypoxemia, signs of hypercapnia) AND signs of pulmonary overload (clinical, biological and radiological arguments).
* Having given their non-objection to participation in the study (or non-objection of a loved one in an emergency context)
Exclusion Criteria:
* Breastfeeding in progress
* Known hypersensitivity to furosemide
* History of kidney transplantation
* Known water and electrolyte disorder
* Hepatic encephalopathy
* Suspicion of obstruction in the urinary tract
* Person deprived of liberty by judicial or administrative decision, minor, person subject to a measure of legal protection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05881603
Study Brief:
Protocol Section:
NCT05881603